Arcellx Company

Arcellx is a clinical-stage biotechnology company that provides patients with superior immune cell therapies.
Technology: CAR-T
Industry: CAR-T
Headquarters: Gaithersburg, Maryland, United States
Founded Date: 2015-01-01
Employees Number: 51-100
Funding Status: IPO
Investors Number: 18
Total Funding: 29925605
Estimated Revenue: $10M to $50M
Last Funding Date: 2022-06-15
Last Funding Type: Post-IPO Equity

Visit Website
Register and Claim Ownership